Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Circle strategic commercial alliance with Binance to expand global USDC adoption
We advised Circle in entering into a unique strategic commercial arrangement with Binance to accelerate global USDC adoption
Norwegian Cruise Line $1.8 billion senior notes offering
The high-yield notes are due 2032
Banco Santander $2 billion notes offering
We advised Banco Santander on the offering
Banco Santander $3.5 billion cash tender offers
We advised Banco Santander on its tender offers for fixed-rate notes
Rakuten Group $550 million subordinated notes offering
The 8.125% reset notes are listed on the Singapore Exchange
JBS $1.75 billion senior notes offerings
The investment-grade notes are due 2035 and 2055
Outlook Therapeutics $20.4 million warrant liability transaction
Certain holders agreed to exercise Outlook Therapeutics warrants at a reduced exercise price while receiving new warrants
Arcos Dorados renewal of long-term master franchise agreement with McDonald’s
We advised Arcos Dorados on the transaction
Province of Ontario $3 billion global bond offering
The investment-grade bonds are due 2030
SMFG $3.2 billion senior notes offering
We advised SMFG on its SEC-registered offering of TLAC notes